This is the first prospective study evaluating AV conduction in connection with IL‐6 levels in COVID‐19 patients, where, in addition to a reference sample of healthy controls, each subject represented her/his own control throughout the active and recovery phases of the disease. This evidence concerns the gene IL6 and COVID-19.